High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$348K
$348,605
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| LXEO |
Lexeo Therapeutics, Inc.
|
COO
Discretionary Sell
|
2026-02-18 | $19,294 | S | Form 4 |
| LXEO |
Lexeo Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2026-02-18 | $64,924 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Adler Eric
• Officer • Chief Medical Officer
Discretionary Sell
2025-11-18
$5,701
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Medical Officer
Discretionary Sell
|
2025-11-18 | $5,701 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Robertson Jenny
• Officer • Chief Legal Officer
Discretionary Sell
2025-11-18
$5,089
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Legal Officer
Discretionary Sell
|
2025-11-18 | $5,089 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
See Tai Sandi
• Officer • Chief Development Officer
Discretionary Sell
2025-11-18
$3,578
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Development Officer
Discretionary Sell
|
2025-11-18 | $3,578 | S | Form 4 |
| LXEO |
Lexeo Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-18 | $10,447 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Adler Eric
• Officer • Chief Medical Officer
Discretionary Sell
2025-10-17
$30,242x2
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Medical Officer
Discretionary Sell
|
2025-10-17 | $30,242x2 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Otero Jose Manuel
• Officer • Chief Technical Officer
Discretionary Sell
2025-10-17
$18,913x2
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Technical Officer
Discretionary Sell
|
2025-10-17 | $18,913x2 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Robertson Jenny
• Officer • Chief Legal Officer
Discretionary Sell
2025-10-17
$31,530x2
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Legal Officer
Discretionary Sell
|
2025-10-17 | $31,530x2 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
See Tai Sandi
• Officer • Chief Development Officer
Discretionary Sell
2025-10-17
$34,767x2
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Development Officer
Discretionary Sell
|
2025-10-17 | $34,767x2 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Townsend Richard Nolan
• CEO
Discretionary Sell
2025-10-17
$117,436x2
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-10-17 | $117,436x2 | S | Form 4 |
|
LXEO
S
Lexeo Therapeutics, Inc.
Otero Jose Manuel
• Officer • Chief Technical Officer
Discretionary Sell
2025-08-18
$6,684
|
||||||
| LXEO |
Lexeo Therapeutics, Inc.
|
Officer • Chief Technical Officer
Discretionary Sell
|
2025-08-18 | $6,684 | S | Form 4 |